Salk Institute Identifies New Pancreatic Cancer Treatment Approaches

Researchers at the Salk Institute have elucidated the mechanism by which the drug entinostat affects DNA damage repair genes in pancreatic cancer cells. This foundational discovery has paved the way for novel therapeutic strategies, such as combining entinostat with DNA-damaging treatments and utilizing nanoparticle delivery to minimize side effects. These advancements hold promise for improving pancreatic cancer outcomes.